A Randomized, Open-Label, Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult patients with nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium aviumcomplex (MAC) that are refractory to treatment